Treace Medical Concepts (TMCI) Competitors $6.62 -0.14 (-2.07%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$6.63 +0.01 (+0.15%) As of 04/15/2025 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TMCI vs. ENOV, NVCR, LMAT, CNMD, WRBY, CDRE, KMTS, TNDM, FNA, and INMDShould you be buying Treace Medical Concepts stock or one of its competitors? The main competitors of Treace Medical Concepts include Enovis (ENOV), NovoCure (NVCR), LeMaitre Vascular (LMAT), CONMED (CNMD), Warby Parker (WRBY), Cadre (CDRE), Kestra Medical Technologies (KMTS), Tandem Diabetes Care (TNDM), Paragon 28 (FNA), and InMode (INMD). These companies are all part of the "medical equipment" industry. Treace Medical Concepts vs. Enovis NovoCure LeMaitre Vascular CONMED Warby Parker Cadre Kestra Medical Technologies Tandem Diabetes Care Paragon 28 InMode Treace Medical Concepts (NASDAQ:TMCI) and Enovis (NYSE:ENOV) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, community ranking, dividends, media sentiment and earnings. Which has preferable valuation and earnings, TMCI or ENOV? Enovis has higher revenue and earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Enovis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTreace Medical Concepts$209.36M1.99-$49.53M-$0.90-7.36Enovis$2.11B0.85-$33.26M-$14.29-2.20 Which has more risk and volatility, TMCI or ENOV? Treace Medical Concepts has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500. Comparatively, Enovis has a beta of 1.86, indicating that its stock price is 86% more volatile than the S&P 500. Does the media favor TMCI or ENOV? In the previous week, Treace Medical Concepts had 11 more articles in the media than Enovis. MarketBeat recorded 16 mentions for Treace Medical Concepts and 5 mentions for Enovis. Enovis' average media sentiment score of 0.69 beat Treace Medical Concepts' score of 0.24 indicating that Enovis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 4 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Enovis 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Do institutionals & insiders have more ownership in TMCI or ENOV? 84.1% of Treace Medical Concepts shares are owned by institutional investors. Comparatively, 98.4% of Enovis shares are owned by institutional investors. 24.4% of Treace Medical Concepts shares are owned by insiders. Comparatively, 2.4% of Enovis shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts recommend TMCI or ENOV? Treace Medical Concepts currently has a consensus target price of $9.93, suggesting a potential upside of 49.98%. Enovis has a consensus target price of $58.50, suggesting a potential upside of 86.26%. Given Enovis' stronger consensus rating and higher probable upside, analysts plainly believe Enovis is more favorable than Treace Medical Concepts.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Treace Medical Concepts 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29Enovis 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Is TMCI or ENOV more profitable? Enovis has a net margin of -5.95% compared to Treace Medical Concepts' net margin of -30.33%. Enovis' return on equity of 4.39% beat Treace Medical Concepts' return on equity.Company Net Margins Return on Equity Return on Assets Treace Medical Concepts-30.33% -51.12% -26.36% Enovis -5.95%4.39%2.80% Does the MarketBeat Community favor TMCI or ENOV? Enovis received 6 more outperform votes than Treace Medical Concepts when rated by MarketBeat users. Likewise, 64.00% of users gave Enovis an outperform vote while only 44.83% of users gave Treace Medical Concepts an outperform vote. CompanyUnderperformOutperformTreace Medical ConceptsOutperform Votes2644.83% Underperform Votes3255.17% EnovisOutperform Votes3264.00% Underperform Votes1836.00% SummaryEnovis beats Treace Medical Concepts on 13 of the 18 factors compared between the two stocks. Remove Ads Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMCI vs. The Competition Export to ExcelMetricTreace Medical ConceptsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$416.33M$4.06B$5.33B$7.57BDividend YieldN/A39.49%5.11%4.32%P/E Ratio-6.6927.6321.7317.82Price / Sales1.9950.20379.2094.61Price / CashN/A51.0838.1534.64Price / Book2.965.826.464.00Net Income-$49.53M$67.09M$3.20B$247.23M7 Day Performance-10.66%-0.17%2.86%1.45%1 Month Performance-16.73%-3.20%-8.55%-6.24%1 Year Performance-42.58%14.84%10.47%0.60% Treace Medical Concepts Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMCITreace Medical Concepts2.8318 of 5 stars$6.62-2.1%$9.93+50.0%-44.3%$416.33M$209.36M-6.69250News CoverageENOVEnovis2.2051 of 5 stars$32.41-0.4%$58.50+80.5%-44.7%$1.85B$2.11B-14.806,800Gap DownNVCRNovoCure3.3286 of 5 stars$16.61+0.7%$35.80+115.5%+29.4%$1.83B$605.22M-11.861,320LMATLeMaitre Vascular3.0974 of 5 stars$79.39-0.5%$95.25+20.0%+31.3%$1.79B$219.86M43.38490News CoveragePositive NewsHigh Trading VolumeCNMDCONMED4.706 of 5 stars$55.34-1.6%$77.20+39.5%-35.5%$1.71B$1.31B13.054,100WRBYWarby Parker3.3236 of 5 stars$15.43-2.2%$23.43+51.8%+13.5%$1.60B$771.32M-57.153,491Analyst ForecastCDRECadre3.4227 of 5 stars$28.30+0.5%$37.00+30.7%-7.8%$1.15B$567.56M34.102,240Gap DownKMTSKestra Medical TechnologiesN/A$22.78-2.1%$27.67+21.5%N/A$1.13B$45.82M0.00300Earnings ReportQuiet Period ExpirationNews CoverageTNDMTandem Diabetes Care4.2123 of 5 stars$16.85-0.2%$45.38+169.3%-44.4%$1.12B$940.20M-8.732,600News CoveragePositive NewsGap DownFNAParagon 281.463 of 5 stars$13.04-0.1%$14.20+8.9%+32.0%$1.09B$256.18M-17.61343,000Short Interest ↓News CoverageHigh Trading VolumeINMDInMode2.2476 of 5 stars$15.40-2.0%$22.25+44.5%-12.9%$1.07B$394.82M6.55480Analyst ForecastNews CoveragePositive News Remove Ads Related Companies and Tools Related Companies Enovis Alternatives NovoCure Alternatives LeMaitre Vascular Alternatives CONMED Alternatives Warby Parker Alternatives Cadre Alternatives Kestra Medical Technologies Alternatives Tandem Diabetes Care Alternatives Paragon 28 Alternatives InMode Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TMCI) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Treace Medical Concepts With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TMCI Stock Free TMCI Stock Alerts